Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell
Abstract Background The chimeric antigen receptor-expressing T (CAR-T) cells for cancer immunotherapy have obtained considerable clinical importance. CAR T cells need an optimized intracellular signaling domain to get appropriately activated and also for the proper antigen recognition, the length an...
Main Authors: | Fatemeh Hajari Taheri, Mahmoud Hassani, Zahra Sharifzadeh, Mahdi Behdani, Shahryar Abdoli, Mahtab Sayadi, Kowsar Bagherzadeh, Arash Arashkia, Mohsen Abolhassani |
---|---|
格式: | Article |
語言: | English |
出版: |
BMC
2024-01-01
|
叢編: | BMC Biotechnology |
主題: | |
在線閱讀: | https://doi.org/10.1186/s12896-023-00827-0 |
相似書籍
-
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
由: Mahmoud Hassani, et al.
出版: (2020-03-01) -
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
由: Mahmoud Hassani, et al.
出版: (2020-03-01) -
Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
由: Farideh Ranjibar, et al.
出版: (2018-09-01) -
VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia
由: E. I. Zakharko, et al.
出版: (2024-04-01) -
An Investigation of Vascular Endothelial Growth Factor (VEGFR-1 and VEGFR-2) in Burn Wound Healing
由: L Abdulazeem, et al.
出版: (2022-04-01)